We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+26.18%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$280B
AUM Growth
+$58B
Cap. Flow
-$9.91B
Cap. Flow %
-3.53%
Top 10 Hldgs %
32.38%
Holding
11,014
New
1,506
Increased
4,384
Reduced
3,586
Closed
1,324

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$861M
2
AAPL icon
Apple
AAPL
+$417M
3
JPM icon
JPMorgan Chase
JPM
+$350M
4
TMUS icon
T-Mobile US
TMUS
+$337M
5
AON icon
Aon
AON
+$296M

Sector Composition

Rank Sector Weight
1 Healthcare 3.4%
2 Technology 3.32%
3 Consumer Discretionary 2.87%
4 Financials 2.84%
5 Industrials 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XERS icon
8901
Xeris Biopharma Holdings
XERS
$1.39B
$86K ﹤0.01%
+32,388
New +$113K
CNR
8902
Core Natural Resources Inc
CNR
$4.02B
$86K ﹤0.01%
16,936
-70,781
-81% -$441K
TRQ
8903
CALL
DELISTED
Turquoise Hill Resources Ltd
TRQ
$86K ﹤0.01%
11,680
+6,080
+109% +$35.8K
MNOV icon
8904
CALL
MediciNova
MNOV
$65.5M
$85K ﹤0.01%
+15,700
New +$83.2K
WTTR icon
8905
Select Water Solutions
WTTR
$2.3B
$85K ﹤0.01%
17,295
-38,483
-69% -$176K
USX
8906
PUT
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$85K ﹤0.01%
14,100
+2,800
+25% +$12.8K
ACTG icon
8907
CALL
Acacia Research
ACTG
$428M
$84K ﹤0.01%
20,500
+8,600
+72% +$24.9K
CNDT icon
8908
CALL
Conduent
CNDT
$244M
$84K ﹤0.01%
35,200
-37,500
-52% -$87.2K
GNPX icon
8909
PUT
Genprex
GNPX
$3.02M
$84K ﹤0.01%
+1
New +$122K
INDP icon
8910
Indaptus Therapeutics
INDP
$172M
$84K ﹤0.01%
132
+78
+144% +$48.2K
MRNS
8911
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$84K ﹤0.01%
8,275
+2,100
+34% +$19.3K
BTG icon
8912
CALL
B2Gold
BTG
$5B
$83K ﹤0.01%
+14,500
New +$72.7K
CLIR icon
8913
CALL
ClearSign Technologies
CLIR
$24.3M
$83K ﹤0.01%
3,990
+140
+4% +$1.33K
OVID icon
8914
CALL
Ovid Therapeutics
OVID
$414M
$83K ﹤0.01%
+11,200
New +$52.4K
PACB icon
8915
PUT
Pacific Biosciences
PACB
$435M
$83K ﹤0.01%
24,100
+4,200
+21% +$14.3K
KA
8916
CALL
DELISTED
Kineta, Inc. Common Stock
KA
$83K ﹤0.01%
431
+49
+13% +$10K
CBAY
8917
CALL
DELISTED
Cymabay Therapeutics
CBAY
$83K ﹤0.01%
23,900
+6,500
+37% +$18.8K
NH
8918
PUT
DELISTED
NantHealth, Inc
NH
$83K ﹤0.01%
+1,207
New +$48.1K
CFRX
8919
DELISTED
ContraFect Corporation
CFRX
$83K ﹤0.01%
+162
New +$79.5K
BCS icon
8920
Barclays
BCS
$92.7B
$82K ﹤0.01%
14,571
-533,772
-97% -$2.78M
GEOS icon
8921
PUT
Geospace Technologies
GEOS
$94.6M
$82K ﹤0.01%
+10,900
New +$72.5K
MGY icon
8922
PUT
Magnolia Oil & Gas
MGY
$6.09B
$82K ﹤0.01%
+13,500
New +$73.7K
MUX icon
8923
CALL
McEwen Inc
MUX
$1.03B
$82K ﹤0.01%
8,100
+3,720
+85% +$34.5K
NNBR icon
8924
NN Inc
NNBR
$255M
$82K ﹤0.01%
17,281
-26,234
-60% -$91.6K
TRST
8925
Trustco Bank Corp NY
TRST
$970M
$82K ﹤0.01%
2,587
-9,529
-79% -$282K

Similar funds

Citadel Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Citadel Advisors held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, down from 4% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Becton Dickinson worth $266M.

  • Citadel Advisors's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
  • Citadel Advisors added most to Amazon in Q2 2020, an estimated $861M increase.
  • Citadel Advisors's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
  • Citadel Advisors fully exited Allergan plc in Q2 2020, selling an estimated $603M.
  • Citadel Advisors's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
  • Citadel Advisors opened 1,506 new positions and closed 1,324 in Q2 2020.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $280B.

Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.